FDA launches new priority review voucher program for select biopharmas

Clene Inc.

FDA
Biotech

FDA unconvinced by Clene’s request for accelerated approval tag

Clene continues to struggle to get anyone else to understand what it sees in CNM-Au8.
James Waldron Dec 21, 2023 8:27am
An artists impression of a motor neuron the body of which is yellow

Clene polishes tarnished ALS asset with long-term survival data

Aug 29, 2023 10:10am
An artists impression of a motor neuron the body of which is yellow

Clene claims ALS therapy hits biomarker behind Qalsody approval

Jun 16, 2023 8:05am
Financial data on a stock ticker

Not so Clene break. Biotech's shares slump 34% on ALS flop

Oct 3, 2022 11:00am